<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01380444</url>
  </required_header>
  <id_info>
    <org_study_id>14032012_INSITE_v2.0</org_study_id>
    <secondary_id>96308751</secondary_id>
    <nct_id>NCT01380444</nct_id>
  </id_info>
  <brief_title>Intramedullary Nail Versus Sliding Hip Screw Inter-Trochanteric Evaluation</brief_title>
  <acronym>INSITE</acronym>
  <official_title>A Multi-Center Randomized Controlled Trial of Intramedullary Nails Versus Sliding Hip Screws in the Management of Intertrochanteric Fractures of the Hip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Trauma GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stryker Osteosynthesis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Global Research Solutions</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stryker Trauma GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the impact of Gamma3 intramedullary nails versus
      sliding hip screws on health-related quality of life as measured by the EuroQuol-5D at 52
      weeks in individuals with trochanteric fractures. Secondary outcomes include revision surgery
      rates, fracture healing rates, fracture related adverse events, and health-related quality of
      life, including the Parker mobility score and Harris Hip Score.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hip fractures are becoming a more prevalent issue worldwide, leading to profound morbidity,
      and in some cases, mortality. Currently the most common method of surgical treatment includes
      the use of a sliding hip screw over a Gamma intramedullary nail, but there is conflicting
      evidence regarding which device has a lower revision surgery rate and complication rate.
      Recent improvements in implant design of the Gamma3 nail, demonstrating decreased rates of
      femoral shaft fractures and improved function, provide compelling rationale for the conduct
      of a large, definitive trial.

      This trial is a definitive, multi-center, concealed randomized controlled trial. Surgeons
      will use one of the two surgical strategies in patients who have sustained a trochanteric
      fracture; the Gamma3 intramedullary nail or the sliding hip screw. Clinical assessments will
      occur at the time of hospital admission, post-surgery, 13 weeks, 26 weeks, 52 weeks, and 104
      weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2011</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>Up to 104 weeks</time_frame>
    <description>To assess the impact of Gamma3 intramedullary nails versus sliding hip screws on health-related quality of life as measured by the EuroQol-5D at 52 weeks in individuals with trochanteric fractures.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>Up to 104 weeks</time_frame>
    <description>To assess the impact of Gamma3 intramedullary nails versus sliding hip screws on health-related quality of life as measured with the Parker mobility score and the Harris Hip Score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fracture healing rates</measure>
    <time_frame>Up to 104 weeks</time_frame>
    <description>A fracture is to be considered healed when there is obliteration of the fracture lines by newly formed bone along the cortices and within the trabecular bone on anteroposterior and lateral (or oblique) radiographs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fracture-related adverse events</measure>
    <time_frame>Up to 104 weeks</time_frame>
    <description>Including mortality, femoral shaft fracture, avascular necrosis (although rare in trochanteric fractures), nonunion, malunion (shortening, varus deformity, valgus deformity and rotational malunion), implant breakage or failure, and infection (i.e., superficial and deep).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision surgery rates</measure>
    <time_frame>Up to 104 weeks</time_frame>
    <description>Any unplanned surgery after the initial fixation to promote fracture healing (non-union), relieve pain (avascular necrosis, early or late implant failure), treat infection, or improve function will be considered a study event.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">880</enrollment>
  <condition>Femoral Neck Fractures</condition>
  <condition>Intertrochanteric Fracture</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gamma3 Intramedullary Nails</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sliding Hip Screws</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gamma3 Intramedullary Nails (Stryker)</intervention_name>
    <description>The Gamma3 nail is cannulated for Guide-Wire-controlled insertion, and features a conical tip for optimal alignment with the inner part of the cortical bone. A single distal Locking Screw is provided to stabilize the nail in the medullary canal and to help to prevent rotation in complex fractures.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Gamma Nail</other_name>
    <other_name>Gamma3 Nail</other_name>
    <other_name>Intramedullary Nail (IM Nail)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sliding Hip Screws</intervention_name>
    <description>The sliding hip screw is a single larger diameter partially threaded screw, which is affixed to the proximal femur with a side plate (with a minimum of two holes and a maximum of four holes) and no supplemental fixation.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Sliding Hip Screw (SHS)</other_name>
    <other_name>Dynamic Hip Screw (DHS)</other_name>
    <other_name>Compression Screw and Side Plate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult men or women aged 18 years and older (with no upper age limit).

          2. An intertrochanteric fracture (stable or unstable), AO Type 31-A1 or 31-A2, confirmed
             with anteroposterior and lateral hip radiographs, computed tomography, or magnetic
             resonance imaging (MRI).

          3. Low energy fracture (defined as a fall from standing height).

          4. No other major trauma.

          5. Patient was ambulatory prior to fracture, though they may have used an aid such as a
             cane or a walker.

          6. Anticipated medical optimization of the patient for operative fixation of the proximal
             femur.

          7. Operative treatment within 7 days after the trauma.(Operative treatment should take
             place as soon as possible as permitted by each institution's standard of care.)

          8. Provision of informed consent by patient or proxy.

        Exclusion Criteria:

          1. Associated major injuries of the lower extremity (i.e., ipsilateral and/or
             contralateral fractures of the foot, ankle, tibia, fibula, or knee; dislocations of
             the ankle, knee, or hip).

          2. Retained hardware around the affected proximal femur.

          3. Infection around the proximal femur (i.e., soft tissue or bone).

          4. Patients with disorders of bone metabolism other than osteoporosis (i.e., Paget's
             disease, renal osteodystrophy, or osteomalacia).

          5. Patients with Parkinson's disease severe enough to increase the likelihood of falling
             or severe enough to compromise rehabilitation.

          6. Patients with a subtrochanteric fracture.

          7. Patients with a pathologic fracture.

          8. Patients with a reverse oblique fracture pattern, fracture AO Type 31-A3.

          9. Obesity in the judgment of the attending surgeon.

         10. Off-label use of the implant.

         11. Patients with a previous history of frank dementia that would interfere with
             assessment of the primary outcome (i.e., EQ-5D at 1 year).

         12. Likely problems, in the judgment of the Site Investigators, with maintaining
             follow-up. We will, for example, exclude patients with no fixed address, those who
             report a plan to move out of town in the next year, or intellectually challenged
             patients without adequate family support.

         13. Patient is enrolled in another ongoing drug or surgical intervention trial.

         14. If the attending surgeon believes that there is another reason to exclude this patient
             from INSITE. This reason will be documented on the case report forms (CRFs).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohit Bhandari, MD, PhD, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Global Research Solutions</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georgia Mitchell</last_name>
    <role>Study Director</role>
    <affiliation>Stryker Trauma GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Community Regional Medical Center</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93721</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott&amp;White Memorial Hospital</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal Melbourne Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3039</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Sciences Centre Winnipeg</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A 1R9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 1R6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaoyang Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sixth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200233</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>2nd Affiliated Hospital of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica El Rosario Sede El Tesoro</name>
      <address>
        <city>Medellin</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Santa Clara</name>
      <address>
        <city>Bogotá</city>
        <state>Cundinamarca</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein, Campus Lübeck</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert-Bosch-Krankenhaus</name>
      <address>
        <city>Stuttgart</city>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tsukuba Medical Center</name>
      <address>
        <city>Tsukuba City</city>
        <state>Ibaraki</state>
        <zip>305-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <zip>1091</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helse Sunnmore Alesund Sjukehus</name>
      <address>
        <city>Alesund</city>
        <zip>6026</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlotte Maxeke Johannesburg Academic Hospital</name>
      <address>
        <city>Parktown</city>
        <zip>2193</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frenchay Hospital</name>
      <address>
        <city>Bristol</city>
        <zip>BS16 1LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal Liverpool University Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal Berkshire Hospital</name>
      <address>
        <city>Reading</city>
        <zip>RG1 5AN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>South Africa</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Spain</country>
  </removed_countries>
  <reference>
    <citation>Ahrengart L, Törnkvist H, Fornander P, Thorngren KG, Pasanen L, Wahlström P, Honkonen S, Lindgren U. A randomized study of the compression hip screw and Gamma nail in 426 fractures. Clin Orthop Relat Res. 2002 Aug;(401):209-22.</citation>
    <PMID>12151898</PMID>
  </reference>
  <reference>
    <citation>Bhandari M, Schemitsch E, Jönsson A, Zlowodzki M, Haidukewych GJ. Gamma nails revisited: gamma nails versus compression hip screws in the management of intertrochanteric fractures of the hip: a meta-analysis. J Orthop Trauma. 2009 Jul;23(6):460-4. doi: 10.1097/BOT.0b013e318162f67f.</citation>
    <PMID>19550235</PMID>
  </reference>
  <reference>
    <citation>Parker MJ, Handoll HH. Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD000093. doi: 10.1002/14651858.CD000093.pub4. Review. Update in: Cochrane Database Syst Rev. 2010;(9):CD000093.</citation>
    <PMID>18646058</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2011</study_first_submitted>
  <study_first_submitted_qc>June 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2011</study_first_posted>
  <last_update_submitted>April 21, 2017</last_update_submitted>
  <last_update_submitted_qc>April 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intertrochanteric fracture</keyword>
  <keyword>Gamma3 intramedullary nail</keyword>
  <keyword>Sliding hip screw</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Femoral Neck Fractures</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

